scispace - formally typeset
D

David A. Relman

Researcher at Stanford University

Publications -  333
Citations -  56633

David A. Relman is an academic researcher from Stanford University. The author has contributed to research in topics: Microbiome & Metagenomics. The author has an hindex of 90, co-authored 310 publications receiving 49513 citations. Previous affiliations of David A. Relman include University of Texas Medical Branch & The Advisory Board Company.

Papers
More filters
Journal ArticleDOI

Diversity of the human intestinal microbial flora.

TL;DR: A majority of the bacterial sequences corresponded to uncultivated species and novel microorganisms, and significant intersubject variability and differences between stool and mucosa community composition were discovered.
Journal ArticleDOI

Metagenomic Analysis of the Human Distal Gut Microbiome

TL;DR: Using metabolic function analyses of identified genes, the human genome is compared with the average content of previously sequenced microbial genomes and humans are superorganisms whose metabolism represents an amalgamation of microbial and human attributes.
Journal ArticleDOI

Development of the human infant intestinal microbiota.

TL;DR: A microarray is designed to detect and quantitate the small subunit ribosomal RNA (SSU rRNA) gene sequences of most currently recognized species and taxonomic groups of bacteria and suggested that incidental environmental exposures play a major role in determining the distinctive characteristics of the microbial community in each baby.
Journal ArticleDOI

The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing

TL;DR: Ciprofloxacin treatment influenced the abundance of about a third of the bacterial taxa in the gut, decreasing the taxonomic richness, diversity, and evenness of the community, and support the hypothesis of functional redundancy in the human gut microbiota.
Journal ArticleDOI

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation

TL;DR: The effect of ciprofloxacin on the gut microbiota was profound and rapid, with a loss of diversity and a shift in community composition occurring within 3–4 d of drug initiation and 1 wk after the end of each course, but the return was often incomplete.